Skip to main content
. 2026 Apr 24;51(1):409–420. doi: 10.1159/000552201

Fig. 2.

Figure 2: Risk-of-bias assessment of 18 randomized controlled trials using Cochrane RoB 2 across five domains. Most studies were judged as low risk or some concerns, with low risk most common for missing data, outcome measurement, and selective reporting.

Risk-of-bias assessment for included studies. Summary of authors’ judgments across five Cochrane RoB 2 domains for the 18 included RCTs. Green = low risk; yellow = some concerns/unclear risk.